Tech Company Financing Transactions
Esanex Funding Round
Esanex closed a $5 million funding round on 6/30/2012. Investors included Intersouth Partners.
Transaction Overview
Company Name
Announced On
6/30/2012
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
115 W. Washington St. 1680
Indianapolis, IN 46204
USA
Indianapolis, IN 46204
USA
Phone
Email Address
Not Recorded
Overview
Esanex is a biotechnology company developing a best-in-class Hsp90 inhibitor to fight various forms of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Hall
Browse more venture capital transactions:
Prev: 6/30/2012: Cerebrotech Medical Systems venture capital transaction
Next: 6/30/2012: Smile venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs